Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancers
- 1 October 1993
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 53 (2) , 135-144
- https://doi.org/10.1002/jcb.240530206
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Regulation of urokinase plasminogen activator localization in keratinocytes by calcium ion and E-cadherinExperimental Cell Research, 1992
- Increase of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1) in plasma after thrombolytic therapy of patients with myocardial infarction. A randomised, placebo-controlled studyFibrinolysis, 1992
- Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancerFibrinolysis, 1990
- Plasminogen Activators in Human Prostate Cancer Cell Lines and Tumors: Correlation with the Aggressive PhenotypeJournal of Urology, 1989
- Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor.Proceedings of the National Academy of Sciences, 1989
- Functional inhibition of endogenously produced urokinase decreases cell proliferation in a human melanoma cell line.Proceedings of the National Academy of Sciences, 1989
- Surface receptors for urokinase plasminogen activatorFibrinolysis, 1988
- Effect of urokinase on the proliferation of primary cultures of human prostatic cellsThrombosis Research, 1987
- Identification and localization of urokinase‐type plasminogen activator in human NK‐cellsInternational Journal of Cancer, 1986
- Plasminogen Activators, Tissue Degradation, and CancerPublished by Elsevier ,1985